In general, colon, pancreas, and lung carcinoma are associated with KRAS mutation, while somatic TP53 mutations occur in almost every type of cancer, with the highest rates in ovarian, esophageal, colorectal, head and neck, larynx, and lung cancers [26,105,106]. This evidence concerns the gene KRAS and cancer.